Statement concerning COVID-19
Dear Customer: As an entrusted partner and service provider to you and your company, we would like to assure you that HTI is taking precautions not only to maintain business…
Edgewater Capital Partners to Acquire Haematologic Technologies
Joint News Release HTI Media Contact:Robert Myers, VP of Business DevelopmentTel.: (802) 878-1777Email: rmyers@haemtech.net Edgewater Media Contact:Robert Girton, PartnerTel.: (216) 292-3858Email: rgirton@edgewatercapital.com Edgewater Capital Partners to Acquire Haematologic Technologies Essex Junction,…
Does your drug create a clotting problem?
When evaluating drug candidates that treat hemostasis directly, or those that have potential off-target coagulation effects, understanding their impact on blood coagulation is essential. Several assays can measure a drug…